Giovanni Lagalla

Summary

Country: Italy

Publications

  1. doi request reprint Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling
    Giovanni Lagalla
    Clinica Neurologica, Dipartimento di Neuroscienze, Universita Politecnica delle Marche, Ospedali Riuniti, Ancona, Italy
    J Neurol 256:563-7. 2009
  2. doi request reprint Familial hemifacial spasm and determinants of late onset
    Giovanni Lagalla
    Clinica Neurologica, Dipartimento di Scienze Neurologiche, Az Ospedali Riuniti, Universita Politecnica delle Marche, Via Conca 1, 60020, Ancona, Italy
    Neurol Sci 31:17-22. 2010
  3. ncbi request reprint Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study
    Giovanni Lagalla
    Clinica di Neuroriabilitazione, Dipartimento di Neuroscienze, Universita Politecnica delle Marche, Az Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Mov Disord 21:704-7. 2006

Detail Information

Publications3

  1. doi request reprint Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling
    Giovanni Lagalla
    Clinica Neurologica, Dipartimento di Neuroscienze, Universita Politecnica delle Marche, Ospedali Riuniti, Ancona, Italy
    J Neurol 256:563-7. 2009
    ..To investigate the safety, efficacy and effectiveness of botulinum toxin type-B (BTX-B) injections into the parotid glands to reduce drooling in Parkinson's disease (PD) subjects...
  2. doi request reprint Familial hemifacial spasm and determinants of late onset
    Giovanni Lagalla
    Clinica Neurologica, Dipartimento di Scienze Neurologiche, Az Ospedali Riuniti, Universita Politecnica delle Marche, Via Conca 1, 60020, Ancona, Italy
    Neurol Sci 31:17-22. 2010
    ..The distribution of NVC in several members of the same family suggests a genetic susceptibility towards vascular anomaly...
  3. ncbi request reprint Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study
    Giovanni Lagalla
    Clinica di Neuroriabilitazione, Dipartimento di Neuroscienze, Universita Politecnica delle Marche, Az Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy
    Mov Disord 21:704-7. 2006
    ..01), as well as in saliva production (Time x Group effect: P<0.0001). No adverse events were recorded. BoNTX injections are safe and effective treatment for the management of PD-related drooling...